Spanish Red Biotech Pipeline

PharmaMar

ZEPZELCA (lurbinectedin) + Atezolizumab

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Small cell lung cancer Maintenance
Phase: 3Phase III, 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical